A consensus report published in the journal Bipolar Disorders has outlined the significance of the body's internal clock in the management of bipolar disorder. The report emphasizes the importance of utilizing light exposure, darkness, and daily routines to stabilize mood and enhance sleep quality, aiming to update clinical training and treatment protocols worldwide.

Read More

Bipolar disorder is marked by extreme mood fluctuations, including episodes of mania or hypomania followed by severe depression. While the precise causes of these mood changes are complex and vary among individuals, evidence increasingly points to disrupted circadian rhythms as a key contributing factor.

Circadian rhythms encompass the physical, mental, and behavioral changes that follow a 24-hour cycle, managed by an internal biological clock in the suprachiasmatic nucleus of the brain. This master clock responds to environmental signals such as light and darkness, guiding the body’s sleep-wake cycle.

Chronobiology, the study of biological rhythms, has led to the development of chronotherapies aimed at realigning the body's internal clock to enhance mental and physical health. These therapies can include structured exposure to bright light and regulated daily activities.

Despite emerging evidence linking circadian dysfunction to bipolar disorder, many medical training programs remain insufficiently informed about this relationship. Experts have noted that a review of 25 bipolar disorder treatment guidelines revealed that less than half addressed circadian disturbances.

Jacob Crouse, a senior research fellow at the Brain and Mind Centre at the University of Sydney, highlighted that while the science of chronobiology has been known for nearly 50 years, most clinical guidelines and training programs have not integrated this critical information regarding the management of bipolar disorder. To close this gap, Crouse's team conducted a Delphi study involving 30 experts from diverse regions including North America, South America, Europe, Asia, and Oceania.

The study began with 960 statements about bipolar disorder and chronotherapy, which were narrowed down to 758 for evaluation. Experts rated these statements on a five-point scale based on their importance for clinicians. A consensus was established if at least 80 percent of the experts viewed a statement as essential or important.

Over three rounds of voting, a consensus on 342 statements was achieved, categorized into four primary themes: basic circadian science, circadian health, the chronobiology of bipolar disorder, and specific chronotherapies.

Experts concluded that clinicians must comprehend how the biological clock functions, recognizing light as the most influential environmental cue. They also agreed that melatonin serves as a chemical marker for darkness, inhibiting wakefulness during daytime.

The panel identified the ramifications of a misaligned biological clock, linking irregular sleep and wake patterns to increased mood instability. Adjusting light exposure—specifically boosting morning light and reducing evening light—can help reset the biological clock.

Notably, the experts acknowledged that a dysfunctional body clock could be a primary cause of mood cycles in bipolar disorder. They pointed out that seasonal changes often trigger mood episodes, and poor sleep can exacerbate symptoms.

The largest theme discussed was chronotherapies, with experts agreeing on the necessity of understanding various treatment protocols. Bright light therapy, which involves exposure to a specific intensity of light, was identified as a potential antidepressant during depressive episodes. Dark therapy, using special glasses to block blue light in the evening, was found to enhance sleep and possibly alleviate mania symptoms.

The consensus also touched on the use of supplemental melatonin, which has not sufficient clinical backing for acute bipolar depression. However, taking melatonin before bedtime can send a strong signal to the circadian clock.

Interpersonal and Social Rhythm Therapy was endorsed as an important concept, focusing on managing daily routine regularity. Patients learn to track their daily activities, which aids in identifying disruptions to their rhythms.

Other therapies reviewed included wake therapy and adjustments to sleep hygiene, with the latter addressing cognitive aspects interfering with healthy sleep. Crouse emphasized the need to better disseminate this knowledge to improve care for individuals with bipolar disorder, encouraging patients to advocate for themselves concerning their treatment options.

Challenges in the study included geographic limitations in the expert panel, excluding contributors from certain regions, and a predominance of psychiatrists in the assessments. Crouse expressed a commitment to broadening the implementation of chronobiology into mental health practice and developing accessible educational materials for clinicians. The report, entitled “Essential Information About Chronobiology and Chronotherapy for the Optimal Care of People With Bipolar Disorders: An Expert Consensus,” outlines these critical insights.